Sarvodaya Hospital in Faridabad has become India’s first Theranostics Center to offer Terbium-161 PSMA therapy for advanced prostate cancer patients. In addition to this groundbreaking therapy, the hospital now provides CAR-T Cell therapy, an advanced treatment for blood cancers like leukemia, lymphoma, and multiple myeloma, making it a one-stop destination for comprehensive cancer care. Dr. Swagat Dash, leading the initiative, expressed optimism about the impact of this therapy on patients with advanced prostate cancer, emphasizing the hospital’s commitment to delivering cutting-edge cancer care and advancing precision oncology. Dr. Dinesh Pendharkar highlighted the importance of evidence-based techniques in improving patient outcomes and described Terbium-161 PSMA therapy as a novel approach that redefines complete cancer care, alongside CAR-T Cell therapy and Theranostics.
The introduction of Terbium-161 PSMA therapy at Sarvodaya Hospital signifies a significant advancement in precision oncology and offers renewed hope to patients with advanced prostate cancer in India. This pioneering initiative not only showcases the hospital’s dedication to innovative cancer treatments but also marks a shift in the landscape of cancer care. With a focus on precision and evidence-based care, Sarvodaya Hospital is at the forefront of revolutionizing cancer treatment in the country, setting new standards for comprehensive and advanced therapies to combat various types of cancers.
Read more from theprint.in
